Don Mattison's career is an amalgamation of medicine, science, and public service. He started with a Bachelor's degree in Chemistry and Mathematics, followed by a Master's from MIT in Chemistry. He then pivoted to medicine, obtaining an MD from Columbia University and focusing on pharmacology and toxicology in reproductive health during his residencies. Mattison has held several prestigious appointments, including Dean of the University of Pittsburgh's Graduate School of Public Health and Chief Medical Officer at Risk Sciences International. Throughout his career, he obtained medical licenses in six U.S. states and served in the U.S. Public Health Service, retiring with the rank of Captain. Most recently, he became a Distinguished Professor of Epidemiology at the University of South Carolina.

With a B.Math, M.Sc, and Ph.D in Statistics from Carleton University, Shintaro Hagiwara specialized in optimal design for quantitative high-throughput screening and a value-of-information framework for regulatory decision-making. He honed his communication skills through teaching and consulting roles at Carleton. Since joining Risk Sciences International in 2023, his focus has been on applying the VOI framework and developing health-based guideline values for chemicals.

Dr. Khan is a medical doctor with a master's in public health and a Ph.D. in population health. He currently holds a CIHR-CMHC joint fellowship applying deep learning and geospatial intelligence to predict and map cancer risk from radon gas exposure, collaborating with the University of Calgary's School of Architecture and School of Medicine. Dr. Khan also consults for the WHO on emergency health security and works as a research associate focusing on developing a next-generation risk assessment framework using new approach methodologies. His experience includes various roles in healthcare, academia, and international organizations, including the World Health Organization. Dr. Khan's expertise covers global public health, digital surveillance, population health risk assessment, advanced data analytics, and more. He has received multiple awards and published numerous peer-reviewed research articles in high-ranking journals.

Dr. Patricia Larkin's career is dedicated to policy and regulatory assessments, focusing on the intersection of social determinants of health and health equity. Her expertise lies in managing human health and environmental risks, particularly in energy, water resources, and climate change. Patricia's research explores Canadian innovation in energy regulatory decision-making and its impact on risk management. She has led interdisciplinary international research projects, addressing risk management in public decision-making and environmental issues like carbon capture and storage. As Chair of the Applied Risk Management Specialty Group of the Society for Risk Analysis, she continues to contribute to this field.

Emma Hartnett is an internationally recognized expert in risk assessment, specializing in toxicological, microbiological, and nutritional hazards. She holds a B.Sc. in Microbiology and a Ph.D. in Statistics and Modelling Science, where her thesis work focused on quantitative risk assessment for campylobacter infection from chicken. Hartnett has developed a variety of decision support tools addressing issues from infectious diseases to bioterrorism preparedness. She frequently contributes to WHO and FAO initiatives, and has been selected for the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment Roster of Experts for 2018-2022.

Dr. Cote boasts over 35 years of expertise in public health risk assessment and environmental management. She advises governments and industries on chemical exposure risks and risk assessment implementation. An adjunct professor at the University of Colorado, she educates on environmental health, risk assessment, and public policy. Dr. Cote also teaches risk assessment at Rutgers University. Her research focuses on cancer, respiratory diseases, and enhancing risk assessment methods. She spent 27 years at the US Environmental Protection Agency, serving in roles like Senior Science Advisor, Division Director, and Associate Laboratory Director. Dr. Cote's influence extends globally, advising organizations like the World Health Organization and the National Institutes of Health.

Dr. Calvin Willhite is a renowned expert in developmental toxicology and quantitative structure-activity relationships, with a substantial publication record. He has played key roles in influential organizations and committees, including the National Academy's Committee on Toxicology, the U.S. EPA's National Advisory Committee, and the IARC Cancer Chemoprevention Panel. Dr. Willhite is a member of the Society of Toxicology and is featured in notable biographical publications. Currently, he serves as an Associate Expert with Risk Sciences International, contributing to health risk assessments for various chemicals, both man-made and naturally-occurring.

Todd Ruthman graduated from the University of Waterloo in 1992 with a BASc in Systems Design Engineering. This educational background instilled in him a fascination for understanding the integrated interactions among people, nature, and technology. For nearly two decades, he has been applying this multidisciplinary perspective in the development of science-based and risk-based solutions for clients. His team specializes in creating IT solutions that support risk-informed decision-making, utilizing either custom web applications or off-the-shelf software such as Excel, Analytica, and R.

With 45 years of experience in exposure and risk assessment, Dr. Paul Price has worked with diverse organizations, including the U.S. EPA and Dow Chemical. Specializing in mixture risk assessments, he is an adjunct professor at the University of Iowa and serves on the European Food Safety Authority’s committee on combined exposures. A prolific author, Dr. Price is currently focused on publications concerning mixture risk assessment and the Mixture Adjustment Factor.

Martin LeBlanc specializes in business development at RSI, focusing on client needs across various sectors including health, nuclear, and aerospace. With a background in electrical/mechanical technology and sales, he excels in assembling project teams and navigating complex procurement processes. He is adept at contract negotiation, proposal development, and is well-versed in Government of Canada procurement vehicles. Martin is also experienced in international projects and adapts quickly to new procurement processes.